CLNN Clene drops 39 today after reporting a far wider than expected Q4 2025 EPS loss Does Atossa ATOS stock justify its valuation Q4 2025 Earnings Fall Short Indaptus Therapeutics INDP Stock Is It a Good Entry Point Indaptus Therapeutics misses EPS views no revenue SMTI Sanara MedTech reports Q4 2025 lower than expected EPS posts minor share gain despite earnings miss